These findings support the critical role of CD4+ T cells in the obesity-associated TIME and that the reduced anti-tumor activity of CD4+ T cells contributes to the acceleration of tumor growth mediated through an effect on CD8+ T cells. The gene discussed is CD4; the disease is obesity disorder.